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Abstract 
Purpose: Definition of new national diagnostic reference levels (DRLs) for volume 
computed tomography dose index (CTDIvol) and dose length product (DLP) for neuro-
paediatric CT examinations depending on the medical indication. 
Methods: Paediatric cranial CT data sets acquired between January 2013 and 
December 2016 were retrospectively collected between July 2016 and March 2017 
from the eight largest university and cantonal hospitals that perform most of the 
neuro-paediatric CTs in Switzerland. A consensus review of CTDIvol and DLP was 
undertaken for the three defined anatomical regions: brain, facial bone and petrous 
bone; each with and without contrast medium application. All indications for cranial 
CT imaging in paediatrics were assigned to one of these three regions. Descriptive 
statistical analysis of the distribution of the median values for CTDIvol and DLP 
yielded minimum, maximum, 25th percentile (1st quartile), median (2nd quartile) and 
75th percentile (3rd quartile). New DRLs for neuro-paediatric CT examinations in 
Switzerland were based on the 75th percentiles of the distributions of the median 
values of all eight centres. Where appropriate, values were rounded such that the 
DRLs increase or at least remain constant as the age of the patient increases. 
Results: Our results revealed DRLs for CTDIvol and DLP up to 20% lower than the 
DRLs used so far in Switzerland and elsewhere in Europe. 
Conclusions: This study provides Swiss neuro-paediatric CT DRL values to establish 
optimum conditions for paediatric cranial CT examinations. Periodic national updates 
of DRLs, following international comparisons, are essential.  
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Article highlights 
• A retrospective multicentre study enabled new national DRLs to be defined for 
volume computed tomography dose index (CTDIvol) and dose length product 
(DLP) of neuro-paediatric CT examinations in Switzerland. 
• The strength, value, and originality of our method is that we propose new 
DRLs for medical indications. 
• Data analysis of all neuro-paediatric CT scans resulted in DRLs up to 20% 
lower than those presently used in Switzerland and internationally for the three 
defined anatomical regions, brain, facial bone and petrous bone, specified 
according to the medical indication. 
• The new DRLs are aimed to serve as an initial benchmark and guide the 
optimised application of CT protocols in neuroradiology departments in Swiss 
hospitals performing neuro-paediatric CT scans. 
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Keywords: Radiation protection, radiation monitoring, CT, neuro-paediatrics, DRL, 
CTDIvol, DLP 
Abbreviations: 
CM   contrast medium 
CT   computed tomography 
CTDIvol  volume computed tomography dose index 
DLP   dose length product 
DRL   diagnostic reference level 
FOPH  Federal Office of Public Health 
MRI   magnetic resonance imaging 
SL   scan length 
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1. Introduction 
Exposure of children to ionising radiation during computed tomography (CT) 
examinations is a cause for concern. Most neuro-paediatric CT examinations take 
place in emergency situations, and a 5-fold increase in frequency in the United States 
was documented from 1995 to 2008 [1]. This corresponds to a compound annual 
growth rate of 13.2% of paediatric emergency department visits that included a CT 
and a doubling time of approximately 5.6 years [1]. In 2008, CT was performed in 1.7 
million of a total of 27.9 million paediatric visits to the emergency department [1]. 
Owing to its widespread availability, paediatric CT imaging is frequently used to 
enable correct diagnosis in the outpatient setting, e.g. for trauma and craniofacial 
surgery patients, who may undergo multiple head CTs during preoperative treatment 
and follow-up. Craniofacial paediatric CT imaging is commonly used for diagnostic 
evaluation, operative planning, and outcome analysis, despite increasing controversy 
regarding radiation exposure [2, 3]. The general increase of paediatric CT can be 
attributed to the availability of fast helical and multi-detector scanning, reducing the 
need for sedation and allowing the examination of younger, sicker and uncooperative 
children. 
Many university and regional hospitals in Switzerland use low-dose CT 
protocols, which partly limit the diagnostic value in regard to the clinical indication and 
necessity of repetition [4]. Low-dose CT protocols reduce the amount of ionising 
radiation exposure for paediatric patients but image quality and diagnostic utility are 
often significantly compromised. Particularly in neurosurgical practice, children often 
require multiple brain CTs for some conditions e.g. hydrocephalus, intracranial 
haemorrhage, postoperative evaluation and intracranial infectious fluid collections. 
Neurosurgeons are looking for very specific information on the CT images, in terms 
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of the pathology and anatomical position; a decreased image quality may not be 
adequate. MRI – the imaging method of choice for children in most clinical 
circumstances – is not available in every hospital at all times. 
In 2012, Pearce et al. published a retrospective epidemiological study on the 
relationship between paediatric head CTs and increased risk of developing brain 
cancer and leukaemia. The authors reported that CT scans in children resulting in 
cumulative doses of about 50 mGy, could almost triple the risk of leukaemia, 
whereas doses of about 60 mGy might triple the risk of brain cancer [5]. Mathews et 
al. reviewed a large cohort study of 680,000 children in Australia who underwent a 
CT examination between 1985 and 2005; a 24% higher cancer incidence in exposed 
than in non-exposed children was observed [6]. In 2013, the United Nations Scientific 
Committee on the Effects of Atomic Radiation considered the effects of radiation 
exposure on children and concluded that for a given radiation dose, children are 
generally at more risk of tumour induction than adults [7]. This emphasises that the 
estimates of lifetime cancer risk for those exposed as children might be a factor of 2 
to 3 times higher than estimates for a population exposed at all ages [7]. 
These studies, together with the ‘as low as reasonably achievable’ (ALARA) 
concept in radiation protection, triggered worldwide awareness of the need for 
justification of paediatric CT examinations and optimisation of doses [8]. This led the 
International Commission on Radiological Protection (ICRP) to introduce the concept 
of diagnostic reference levels (DRLs) [9]. The objective was to suggest radiation 
dose levels for CTs under defined conditions in standard patients [10]. DRLs are not 
dose limits for individual patient examinations, rather they are used to identify those 
situations in which, for a specific radiological procedure, unusually high or low doses 
necessitate optimisation actions [10–13]. In recent years, DRLs have proved to be a 
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valuable tool to reduce large differences in CT radiation doses between different 
radiological facilities. However, since the DRL is defined as the 75th percentile of the 
dose distribution, there is still a large potential to achieve further dose optimisation 
[10]. 
Paediatric CTs in small- and medium-sized hospitals are obviously performed 
much less often than adult CTs. The medical staff lack relevant experience and the 
use of the paediatric CT protocols is not optimised [14–19]. It is important to pay 
particular attention to paediatric CTs, because children are much more sensitive to 
ionising radiation than adults [16, 17]. Reliable CT scanning in a safe and effective 
manner is challenging in children because body size must be more carefully 
considered, patient cooperation and understanding is often limited or absent, and 
there is a lower tolerance for CT protocol errors in paediatrics [16, 17]. 
The purpose of our retrospective multicentre study was to define new national 
DRLs for volume computed tomography dose index (CTDIvol) and dose length 
product (DLP) of the most frequently performed neuro-paediatric CT examinations in 
Switzerland. These new DRLs are aimed to serve as an initial benchmark and 
provide guidance for the optimised application of CT protocols in neuroradiology 
departments in Swiss hospitals performing paediatric CTs. The strength, value, and 
originality of our study is that we propose DRLs for medical indications. The DRLs of 
other European countries were used for comparison. 
 
2. Materials and methods 
According to the Swiss radiation protection legislation (Radiological Protection 
Ordinance, Article 34, paragraph 2), the radiation protection authority is allowed to 
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collect and process anonymized data of radiological examinations and, for this 
reason, no ethical approval was required for this study. 
  
Data collection 
Paediatric cranial CT data sets acquired between January 2013 and December 2016 
were retrospectively collected during a 9-month period (July 2016 to March 2017) 
from the eight largest university and cantonal hospitals in Switzerland performing 
most of the neuro-paediatric CTs nationwide. The participating hospitals were the 
university hospitals of Geneva, Lausanne, Bern, Basel and Zurich and the cantonal 
hospitals of Chur, Aarau and Lucerne. 
 Anonymised dose data were collected from four Siemens CT scanners 
(Somatom Definition Edge), four GE CT scanners (Brightspeed 8, Discovery 750 HD, 
Lightspeed VCT, Revolution), three Toshiba CT scanners (Aquilion CXL, Aquilion 
One, Aquilion RXL) and one Philips CT scanner (Brilliance CT 64). The cantonal 
hospital of Aarau and the university hospital of Lausanne each provided dose data 
from three CT scanners; the other hospitals provided dose data from one CT 
scanner. In four hospitals, data were collected using commercial dose management 
software; in two hospitals, data were collected using data collection software 
developed in-house; and in two hospitals, data were manually registered in specific 
spreadsheets. The collected dose data were summarised in an Excel spreadsheet 
and sent to the project coordinator for analysis. Throughout the period of data 
collection, the project coordinator maintained close contact with the participating 
centres to provide support and clarification and give feedback when potential for 
increased efficiency was seen. 
 
2.1 Patient data 
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The study population of children aged from 0 to 16 years was classified into four age 
groups: <1.5 years, 1.5 to 5.5 years, 5.5 to 10.5 years, and 10.5 to 16 years. This 
age classification allowed the comparison of the actual Swiss practice in neuro-
paediatric CT to the earlier practice in Switzerland and in other countries. 
 For each child, we gathered the following data: 1. age; 2. date of the CT; 3. 
indication for the CT; 4. exposure data, CTDIvol, and DLP, as well as approximated 
scan length (SL) calculated by dividing the DLP by the CTDIvol; 5. number of scans (if 
scans were repeated; e.g. because of lack of patient cooperation or excessive 
motion). The values used for CTDIvol and the DLP were the displayed values. 
Differences between the displayed and measured CTDIvol were in conformity with 
Swiss legal requirements (limit of ± 20%). 
2.2 CT indications 
A consensus review between the study coordinator, the local physicists collecting the 
data sets and the responsible person of the radiation protection authority of the 
CTDIvol and DLP was undertaken for the following three anatomical regions: brain, 
facial bone and petrous bone; each with and without contrast medium (CM) 
application. All indications for cranial CT imaging were assigned to one of these 
regions. The medical indications for these defined anatomical regions, each with and 
without CM, are summarised in Table1. 
All paediatric neuro CTs analysed were indicated after explicit consultation with the 
clinician and were of sufficient diagnostic image quality with regard to the clinical 
question. None of the scans were acquired only for study purposes. 
 
2.3 Patient data analysis 
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The data acquired were analysed per centre, and stratified according to age group 
and anatomical region; with and without CM. If more than one CT scan had to be 
acquired for a patient, e.g. if the patient had moved or needed several follow-up CT 
scans; each was evaluated separately. 
 For each age group, anatomic region and hospital, median values for CTDIvol 
and DLP were calculated. Descriptive statistical analysis of the resulting distributions 
of the median values yielded values for minimum, maximum, 25th percentile (1st 
quartile), median (2nd quartile), and 75th percentile (3rd quartile). In accordance with 
the recommendations of the ICRP [9], national DRLs were defined as the 75th 
percentiles of the dose distributions. 
The results for brain CTs were compared with the currently valid DRLs in 
Switzerland [20], from L'Institut de Radioprotection et de Sûreté Nucléaire (IRSN) 
France 2009 [21], the American Association of Physicists in Medicine (AAPM) [22] 
and the European Guidelines on DRLs for Paediatric Imaging [23]. For the 
international comparison of the anatomic region of facial bone we used the available 
valid DRLs from Switzerland [20] and the IRSN France [21] and, for petrous bone, 
DRLs from the IRSN France [21], which were the only ones available. Our literature 
search did not yield other comparable DRLs for the anatomic regions of facial bone 
and petrous bone; in our experience the second and third most frequently CT-
examined anatomic regions in children. Note that the survey from L'Institut de 
Radioprotection et de Sûreté Nucléaire (IRSN) France 2009 does not document 
DRLs for children older than 10 years [21]. 
Data were reviewed and processed by an experienced medical physicist, and 
an independent quality assurance check of the processed data was performed. If 
necessary, clarification from the project coordinator was requested. At the end of our 
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study each of the participating centres received a copy of their recorded data to verify 
whether the data were correct and if any comments needed to be added. 
Statistical analysis 
The statistical analysis was performed using R software version 3.3.3 (R: A language 
and environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria). The statistical significance of differences between the different age 
groups for each anatomical localisation was tested with Kruskal-Wallis (significance 
level p = 0.05). 
 
3. Results 
In total, 1645 (100%) paediatric neuro CTs were recorded and retrospectively 
analysed: 1172 (71.2%) brain CTs without CM application; 127 (7.7%) brain CTs with 
CM application; 206 (12.5%) facial bone CTs without CM application; 14 (0.9%) facial 
bone CTs with CM application, 125 (7.6%) petrous bone CTs without CM application 
and 1 (0.1%) petrous bone CT with CM application. The total frequencies of all types 
of examination are given in Table 2. 
The number of CTs with CM application was very low; dose data for CTs with 
and without CM application for the three anatomic regions (results in the appendix) 
were pooled for further analysis. For most of the studies with CM application the 
same CT protocol with the same scanning parameters were used as for native CT 
studies. In Table 3, the 75th percentiles of the distribution of the median values of all 
eight centres for CTDIvol and DLP are presented for the three anatomic regions. The 
values for CTDIvol and DLP recorded for each centre separately are documented in 
the appendix. 
The comparison of the 75th percentiles of the distribution of the median values 
of all eight centres for CTDIvol and DLP for brain CTs to the currently valid DRLs in 
Page 11 of 43 AUTHOR SUBMITTED MANUSCRIPT - JRP-101192.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pt
d M
an
us
cri
pt
12 
 
Switzerland [20], from IRSN France [21], the AAPM [22] and the European 
Guidelines on DRLs for Paediatric Imaging [23] revealed from 10% up to 40% lower 
values; compare Fig. 1a and 1b. The international comparison of the anatomic 
regions, facial bone and petrous bone, with the available valid DRLs for facial bone 
from Switzerland [20] and the IRSN France [21] and with the available DRLs from the 
IRSN France [21] for petrous bone, also revealed decreases in the 75th percentiles 
from 5% to 70% in comparison to the currently valid values as shown in Figs 2a and 
2b and Figs 3a and 3b. 
For CTDIvol, there was a significant difference between the age classes for the 
brain (p <0.001) and the facial bone (p <0.05), but not for the petrous bone (p = 
0.24). Concerning the DLP value, significant differences between age classes were 
found for the brain (p <0.001), the facial bone (p = 0.01) and the petrous bone (p = 
0.02). 
In contrast, the SL for the three anatomical regions was higher than the 
currently valid values in Switzerland [20], as well as those from IRSN France [21], the 
AAPM [22], and the European Guidelines on DRLs for Paediatric Imaging [23] (see 
appendix). 
In our large cohort of CTs, no wide variations in dose were found between the 
participating hospitals (compare appendix). 
New DRLs for neuro-paediatric CT examinations in Switzerland were based 
on the 75th percentiles of the distributions of the median values of all eight centres. 
Where appropriate, values were rounded such that the DRLs increase, or at least 
remain constant, as the age of the patient increases. From our point of view such 
rounding of the values is practical for hospitals acquiring paediatric CTs. Table 4 
shows the rounded values that were obtained taking the standard deviations into 
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consideration. The new proposed DRLs for the three anatomic regions – brain, facial 
bone and petrous bone – are presented in Table 4 and Figs 4a and 4b.  
 
 
4. Discussion 
Following our study, we established new age-related DRLs for CTDIvol and DLP for 
the most frequently performed neuro-paediatric CT examinations in Switzerland. Our 
results with new DRLs for CTDIvol and DLP up to 20% lower than the DRLs so far 
used in Switzerland, as well as in other European countries (Figs 1 to 3), confirm the 
importance of regular re-assessment of the radiological practice; at least every 3 to 
(maximum) 5 years. As a consequence of our study, new national DRLs were 
established in Switzerland for CTDIvol and DLP for paediatric patients in four defined 
age groups (<1.5 years, 1.5 to 5.5 years, 5.5 to 10.5 years and 10.5 to 16 years) for 
the three main anatomic regions – brain, facial bone and petrous bone.  
DRLs are considered to be dynamic values that are reviewed periodically [24]. 
DRLs for indication-based CTs in Switzerland were established for adults in 2010 
[25]. Results showed large variations in doses between different radiology 
departments in Switzerland, especially for examinations of the petrous bone, pelvis, 
lower limbs and heart, indicating that the concept of DRLs was not being correctly 
applied for CTs in clinical routine in Switzerland. 
 A dose optimisation process should be triggered resulting in a lower radiation 
dose, especially in children. By repeatedly implementing such reviews, the global 
radiation dose is expected to decrease over a (short) period of time [15,25–29]. 
As our study demonstrated, a multidisciplinary collaboration between different 
centres is essential when developing and implementing dose-optimised CT protocols 
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beyond institutional single-centre boundaries. As shown, each participating centre 
provided a different amount of CT data depending on the hospital’s size. 
Since there was no statistically significant difference between dose data with 
and without CM application for the three defined anatomic regions and the number of 
CTs with CM was very low, the dose data were pooled for analysis. This decision 
was supported by the data evaluation, which revealed that for most of the studies 
with CM the same CT protocol was used with the same scanning parameters as for 
native CT studies. The pooling increased the statistical power and led to more 
reliable results. 
The routine use of dose management software during CT scanning might also 
have an influence on the results. Centres using commercial or in-house developed 
dose management software provided more data than centres collecting dose data 
manually. The new Swiss DRLs for CTDIvol and DLP are much lower than the current 
Swiss DRLs and the DRLs of other European countries, indicating the use of dose-
optimised CT protocols. Nevertheless, SLs were slightly higher than current values 
and the DRLs of other European countries suggesting a non-optimised radiological 
practice. The scan range chosen was too conservative and emphasises the need for 
continuation of efforts towards the optimisation of CT protocols. 
Radiation dose must not be the only criterion considered when choosing the 
appropriate imaging modality for children. Some of the indications listed in Table 1 
could be examined adequately with MRI. But MRI is not always practical or 
preferable: particularly in acute trauma patients needing rapid treatment, CT is the 
preferred modality. Therefore, it is important to have CT protocols in place that 
minimise radiation dose without sacrificing diagnostic accuracy. Unfortunately, in 
practice, DRLs have not changed significantly over time [24]. Even though DRLs are 
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currently the best tools for dose optimisation, the concept of DRLs only seems to 
work slowly. The DRL values set by different countries for brain CT examinations in 
children have changed little in recent years; several countries published current 
DRLs (2010–2014) that are equal to or even higher than the initial paediatric DRLs 
[24]. Although the ALARA principle is now more than 35 years old [30], and was 
introduced in paediatric imaging more than 10 years ago [8], it seems that there is 
still work to be done on dose optimisation in paediatric brain CT scans. This is 
highlighted by our current results with DRLs for CTDIvol and DLP up to 20% lower 
than the DRLs so far used in Switzerland as in other European countries. 
There is no doubt that such regular data collection and re-evaluation is time 
and resource consuming, but since the Swiss legislation demands the 
implementation of DRLs and since dose management systems are increasingly 
installed in radiology departments allowing automatic data collection, this will 
facilitate such an endeavour.  
A major element of that process of optimisation is a national and international 
consensus on the DRLs to avoid wide variations and minimise radiation risk and 
long-term complications in children. We recommend a timeframe of 3 to a maximum 
of 5 years. In future, it would be worthwhile to suggest DRLs for sub-specific cranial 
CT indications that might have different image quality requirements. 
 
5. Limitations 
The number of paediatric cranial CTs performed in Switzerland is limited. There are 
relatively few paediatric patients owing the small population and low number of 
university, cantonal and regional hospitals compared to other European countries. 
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The small amount of dose data inevitably results in decreased statistical accuracy. 
However, since one of the aims of this study was to harmonise the CT practice 
across Switzerland, all available data was included for analysis.  
 
We are also aware that the different methods of data collection in the eight hospitals 
– using commercial dose management software; in-house developed data collection 
or manual data registration in specific spreadsheets – might have an influence on the 
amount and correctness of collected data. Commercial dose management software 
accesses all dose date from the DICOM header whereas manual data collection 
might be biased in terms of number and accuracy. 
To improve statistical accuracy, the calculation of the 75th percentile of a dose 
distribution should be based on at least 20 data sets, as recommended by the ICRP 
in publication 135 on DRLs in medical imaging [9]. However, since the number of 
neuro-paediatric CT scans in Switzerland is limited, several hospitals provided many 
fewer than 20 data sets for specific examinations (see Table 2). If these data were to 
be omitted from the analysis, DRLs would be based on data from only a few hospitals 
and would not reflect the overall CT practice across Switzerland. Therefore, in order 
to harmonise the CT practice across Switzerland, we decided to include all data in 
our analysis, being fully aware that the statistical accuracy was decreased. 
Image quality of the CT scans was assessed in a qualitative manner by the clinicians 
depending on the clinical indication. Image quality was considered to be sufficient if it 
allowed an accurate diagnosis. No quantitative image quality assessment (e.g. by 
calculating the signal-to-noise ratio or using model observers) was performed, since 
this would have gone beyond the scope of this study.  
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6. Conclusion 
This article reports results from a national dose survey of neuro-paediatric CT 
examinations (1645 data sets were analysed) in eight participating university and 
cantonal hospitals in Switzerland. Results with DRLs for CTDIvol and DLP up to 20% 
lower than the DRLs so far used in Switzerland and other European countries, 
indicate that regular national and international updates of DRLs are essential. With 
respect to the rapidly evolving technology allowing a lower exposure to radiation 
while maintaining a high image quality sufficient for a correct diagnosis, periodic 
updates of regional and international DRLs at least every 3 to a maximum of 5 years 
are indispensable to establish optimum conditions for paediatric brain CTs. 
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TABLES 
Table 1 
Indications for cranial computed tomography (CT) imaging in paediatrics assigned to 
the three anatomic subgroups: brain, facial bone and petrous bone, with and without 
contrast medium (CM). 
 
Anatomical Region Medical Indication 
Brain without CM application 
• brain trauma 
• child abuse 
• evaluation of ventricular width (e.g. in patients with  
suspected shunt dysfunction) 
• localisation of brain pressure probes 
• preoperative determination of extent of  
craniosynostosis 
• dysmorphia of the skull 
• detection and evaluation of calcifications (e.g. in  
syndromes such as Sturge-Weber) 
Brain with CM application 
• in complicated mastoiditis to rule out intracranial  
complications like sinus vein thrombosis, intracranial  
abscess, or Bezold’s abscess 
• central and anterior skull-base tumours (e.g. fibrous  
dysplasia, ossifying fibroma, ecchordis physalliphora) 
• for staging of systemic diseases like Langerhans  
histiocytosis or mastocytosis with multifocal brain  
manifestations 
Facial bone without CM application 
• midface trauma (fracture evaluation) including the  
paranasal sinus, nose and orbit 
• choanal atresia and stenosis of piriform aperture 
• polyposis nasi, Morbus Widal and evaluation of  
uncomplicated sinusitis 
• dentogenic pathologies (e.g. periradicular cysts) 
• for foreign body localisation after midface trauma or in 
case of ingestion 
• juvenile temporomandibular arthropathy 
Facial bone with CM application 
• complicated sinusitis 
• acute and chronic osteomyelitis of midface and anterior 
skull, as well as recurrent infections (e.g. recurrent 
multifocal osteomyelitis in children) 
• osteonecrosis (e.g. radiogenic induced) 
• suspected nasal, paranasal or orbital tumours 
• tumour-like lesions and temporomandibular joint tumours 
(e.g. chondromatosis) 
Petrous bone without CM application 
• congenital anomalies of the temporal bone, middle  
ear cavity, and inner ear 
• for postoperative cochlear implant location, or  
localisation of hearing aids 
Petrous bone with CM application 
• in complicated mastoiditis to rule out periauricular  
complications like Bezold’s abscess 
• posterior skull-base tumours (e.g. fibrous dysplasia,  
ossifying fibroma) 
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• staging of systemic diseases like Langerhans  
histiocytosis or mastocytosis with focal posterior  
skull-base manifestation 
• acute or chronic osteomyelitis, as well as recurrent  
infections of posterior skull-base  
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Table 2 
Total frequencies of all types of examinations at all eight participating centres. 
Centres  
Brain 
without CM  
Brain 
with CM 
Facial Bone 
without CM 
Facial Bone 
with CM 
Petrous Bone 
without CM 
Petrous Bone 
with CM 
Total number 
of CT’s 
Total % of 
CT’s 
A 149 16 34 4 23 1 227 14 
B 130 31 18 2 17 0 198 12 
C 17 0 5 1 3 0 26 2 
D 38 0 4 1 9 0 52 3 
E 28 11 2 1 9 0 51 3 
F 39 10 29 3 21 0 102 6 
H 309 25 47 0 0 0 381 23 
I 462 34 67 3 43 0 609 37 
Total number 
of CT’s 
1172 127 206 14 125 1 1645 - 
Total % of 
CT’s 
71.2% 7.7%  12.5%  0.9%  7.6%  0.1% - 100 
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Table 3  
The new proposed rounded DRLs (75th percentiles) and the target values (median 
values) for CTDIvol and DLP for neuro-paediatric CT examinations, age-related and 
separated according to the three anatomic regions: brain, facial bone and petrous 
bone. For CTDIvol compare Fig. 4a and for DLP compare Fig. 4b. 
 
Anatomical region  
DRLs  
(75th percentile) 
Target value 
(median) 
 
 
Patient’s age 
[years] 
CTDIvol 
[mGy] 
DLP 
[mGy.cm] 
CTDIvol 
[mGy] 
DLP 
[mGy.cm] 
Brain without and 
with CM 
< 1.5 25 350 20 300 
1.5–5.5 30 420 24 390 
5.5–10.5 35 540 30 490 
> 10.5 40 670 36 610 
Facial Bone 
without and with CM 
< 1.5 10 120 7 90 
1.5–5.5 10 120 7 90 
5.5–10.5 15 170 7 110 
> 10.5 15 200 10 140 
Petrous Bone 
without and with CM 
< 1.5 20 110 17 95 
1.5–5.5 30 200 20 110 
5.5–10.5 30 200 20 150 
> 10.5 30 200 20 150 
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FIGURES 
Fig. 1 Comparison of the 75th percentiles for CTDIvol (Fig. 1a) and DLP (Fig. 1b) for 
brain CT scans (black bars) compared to the currently valid DRLs in Switzerland from 
2010 and in France from 2009 as well as to the DRLs published by the AAPM in 
2014 and by the European Commission in 2015. 
 
Fig. 1a
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Fig. 1b 
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Fig. 2 Comparison of the 75th percentiles for CTDIvol (Fig. 2a) and DLP (Fig. 2b) for 
facial bone CT scans (black bars) compared to the currently valid DRLs in 
Switzerland from 2010 and in France from 2009. 
 
Fig. 2a 
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Fig. 2b 
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Fig. 3 Comparison of the 75th percentiles for CTDIvol (Fig. 3a) and DLP (Fig. 3b) for 
petrous bone CT scans (black bars) compared to the currently valid DRLs in France 
from 2009. 
 
Fig. 3a 
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Fig. 3b 
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Fig. 4 The proposed new rounded DRLs (grey bars) based on the 75th percentiles 
(in brackets) for CTDIvol (Fig. 4a) and DLP (Fig. 4b) for neuro-paediatric CT 
examinations; age-related and separated according to the three anatomic regions: 
brain, facial bone and petrous bone. 
 
Fig. 4a 
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Fig. 4b 
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APPENDIX 
A: Median values for CTDIvol, DLP and scan length from all eight centres for CT 
of the brain with and without primary CM application separated by age group. 
 
Table A.1 Paediatric Patients aged <1.5 years, brain CT without CM application. 
 
 
Table A.2 Paediatric patients aged <1.5 years, brain CT with CM application. 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 17 6 13 17 5 6 12 1 1
25th percentile 18 16 13 20 10 8 14 1 13
Median 30 23 13 20 13 20 16 16 16 21
75th percentile 31 26 13 22 13 24 19 16 19
Max 32 30 13 26 21 26 27 29 32
Min 241 18 207 255 108 66 31 25 18
25th percentile 292 202 209 307 151 134 205 30 163
Median 474 314 211 321 186 299 245 182 229 316
75th percentile 530 361 212 339 201 365 273 231 290
Max 723 416 214 395 417 483 390 628 723
Scan length [cm] Median 16 14 16 15 16 15 15 14 15 16
number of exams 26 38 2 10 5 11 64 107 263
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 32 22 n n n 22 14 16 12
25th percentile 32 25 n n n 22 14 16 16
Median 32 26 n n n 22 14 16 20 26
75th percentile 32 26 n n n 22 14 16 26
Max 32 27 n n n 22 14 16 32
Min 321 120 n n n 347 181 136 22
25th percentile 366 630 n n n 347 190 189 197
Median 410 679 n n n 347 199 197 236 410
75th percentile 455 816 n n n 347 208 221 320
Max 500 943 n n n 347 217 251 500
Scan length [cm] Median 13 13 n n n 16 14 12 13 14
number of exams 2 8 0 0 0 1 2 7 20
CTDI [mGy]
DLP [mGy.cm]
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Table A.3 Paediatric patients aged 1.5 to 5.5 years, brain CT without CM application. 
 
 
Table A.4 Paediatric patients aged 1.5 to 5.5 years, brain CT with CM application. 
 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 18 12 16 15 6 24 16 1 1
25th percentile 31 28 16 20 11 25 19 19 19
Median 32 30 16 22 17 26 25 19 19 27
75th percentile 32 30 21 24 17 27 35 19 30
Max 32 44 26 27 17 30 39 40 44
Min 189 22 276 246 77 391 159 13 13
25th percentile 530 390 276 339 188 396 301 252 271
Median 577 416 276 366 300 401 435 271 312 420
75th percentile 630 472 360 426 307 436 515 290 472
Max 803 870 443 521 314 528 932 577 932
Scan length [cm] Median 18 14 18 18 18 16 16 14 15 18
number of exams 31 44 3 19 3 4 69 118 291
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 31 16 n n 5 25 19 14 5
25th percentile 31 29 n n 11 26 19 18 19
Median 31 30 n n 17 26 19 19 27 29
75th percentile 32 32 n n 18 26 31 19 31
Max 32 43 n n 18 31 36 19 43
Min 499 43 n n 89 331 263 252 43
25th percentile 551 345 n n 210 401 277 266 293
Median 596 416 n n 331 409 313 271 405 414
75th percentile 666 454 n n 356 410 480 298 454
Max 791 529 n n 381 446 556 382 791
Scan length [cm] Median 19 14 n n 20 16 15 14 16 18
number of exams 4 8 0 0 3 5 6 4 30
CTDI [mGy]
DLP [mGy.cm]
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Table A.5 Paediatric patients aged 5.5 to 10.5 years, brain CT without CM 
application. 
 
 
Table A.6 Paediatric patients aged 5.5 to 10.5 years, brain CT with CM application. 
 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 29 28 4 16 6 11 4 1 1
25th percentile 31 30 11 21 14 26 28 33 28
Median 32 31 18 21 17 28 36 35 32 33
75th percentile 32 35 20 23 18 31 46 36 36
Max 32 39 30 28 21 33 50 41 50
Min 381 390 51 297 54 254 36 16 16
25th percentile 522 416 186 349 193 429 468 473 452
Median 594 500 285 365 262 462 550 510 511 520
75th percentile 683 543 329 392 309 553 719 547 583
Max 923 621 533 504 385 614 983 838 983
Scan length [cm] Median 19 15 16 17 16 17 16 15 16 17
number of exams 32 12 5 7 4 17 73 114 264
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 30 29 n n 19 27 28 19 15
25th percentile 31 29 n n 20 28 28 35 28
Median 32 29 n n 22 29 36 36 32 35
75th percentile 32 29 n n 27 29 48 36 36
Max 32 29 n n 37 30 48 40 48
Min 261 472 n n 326 460 418 271 216
25th percentile 503 472 n n 378 468 482 510 473
Median 560 472 n n 431 476 515 546 511 538
75th percentile 721 472 n n 538 484 707 583 613
Max 778 472 n n 755 491 815 659 815
Scan length [cm] Median 18 16 n n 19 17 15 15 16 18
number of exams 8 1 0 0 4 2 7 17 39
CTDI [mGy]
DLP [mGy.cm]
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Table A.7 Paediatric patients aged 10.5 to 16 years, brain CT without CM application. 
 
 
Table A.8 Paediatric patients aged 10.5 to 16 years, brain CT with CM application. 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 29 23 26 19 4 23 23 1 1
25th percentile 31 39 26 22 8 30 36 39 31
Median 32 45 39 24 17 32 46 40 40 41
75th percentile 32 45 39 26 20 34 50 40 41
Max 46 53 40 29 27 41 174 41 174
Min 357 451 416 363 77 402 296 22 22
25th percentile 567 631 500 417 151 512 600 576 569
Median 602 676 647 471 340 541 730 617 618 654
75th percentile 719 721 665 525 374 593 873 618 721
Max 1008 808 766 579 492 873 1122 970 1122
Scan length [cm] Median 20 16 17 19 19 17 17 15 16 19
number of exams 60 36 7 2 16 7 103 123 354
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 30 22 n n 17 30 15 40 15
25th percentile 30 41 n n 17 30 28 40 29
Median 31 45 n n 18 30 41 40 40 40
75th percentile 31 50 n n 20 30 49 40 48
Max 31 58 n n 21 30 52 41 58
Min 536 58 n n 270 471 306 576 58
25th percentile 544 570 n n 341 475 557 586 517
Median 551 699 n n 508 479 737 617 617 678
75th percentile 559 721 n n 1049 484 844 617 730
Max 566 808 n n 2396 488 989 618 989
Scan length [cm] Median 18 16 n n 19 16 17 15 16 18
number of exams 2 14 0 0 4 2 10 6 38
CTDI [mGy]
DLP [mGy.cm]
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B: The median value for CTDIvol, DLP and scan length of all eight centres for CT 
of the facial bone with and without primary CM application separated by age 
group. 
 
Table B.1 Paediatric patients aged <1.5 years, facial bone CT without CM 
application. 
 
 
Table B.2 Paediatric patients aged <1.5 years, facial bone CT with CM application. 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 7 6 n n 13 3 n 3 3
25th percentile 7 6 n n 13 4 n 3 5
Median 7 7 n n 13 6 n 6 7 7
75th percentile 7 9 n n 13 8 n 8 8
Max 7 11 n n 13 8 n 8 13
Min 139 71 n n 200 31 n 41 31
25th percentile 139 79 n n 200 36 n 55 52
Median 139 87 n n 200 41 n 75 87 139
75th percentile 139 95 n n 200 56 n 108 121
Max 139 102 n n 200 92 n 159 200
Scan length [cm] Median 19 19 n n 16 10 n 15 12 19
number of exams 1 3 0 0 1 4 0 4 13
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 11 n n 2 n 3 n 8 2
25th percentile 11 n n 2 n 3 n 8 3
Median 11 n n 2 n 3 n 8 6 9
75th percentile 11 n n 2 n 3 n 8 9
Max 11 n n 2 n 3 n 8 11
Min 122 n n 19 n 39 n 99 19
25th percentile 122 n n 19 n 39 n 99 34
Median 122 n n 19 n 39 n 99 69 105
75th percentile 122 n n 19 n 39 n 99 105
Max 122 n n 19 n 39 n 99 122
Scan length [cm] Median 11 n n 10 n 12 n 12 11 12
number of exams 1 0 0 1 0 1 0 1 4
CTDI [mGy]
DLP [mGy.cm]
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Table B.3 Paediatric patients aged 1.5 to 5.5 years, facial bone CT without CM 
application. 
 
 
Table B.4 Paediatric patients aged 1.5 to 5.5 years, facial bone CT with CM 
application. 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 1 5 n 2 5 4 4 6 1
25th percentile 7 6 n 2 5 4 4 6 4
Median 16 9 n 2 5 4 5 6 6 7
75th percentile 16 12 n 2 5 4 10 8 11
Max 18 13 n 2 5 4 36 11 36
Min 15 78 n 16 85 34 38 86 15
25th percentile 95 81 n 17 85 34 45 90 71
Median 176 119 n 18 85 34 69 106 86 113
75th percentile 210 162 n 19 85 34 150 108 164
Max 258 176 n 20 85 34 809 138 809
Scan length [cm] Median 13 14 n 9 16 9 15 14 14 15
number of exams 7 4 0 2 1 1 7 9 31
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 14 n n n 5 n n n 5
25th percentile 14 n n n 5 n n n 9
Median 14 n n n 5 n n n 14 12
75th percentile 14 n n n 5 n n n 22
Max 14 n n n 5 n n n 29
Min 205 n n n 68 n n n 68
25th percentile 205 n n n 68 n n n 136
Median 205 n n n 68 n n n 205 171
75th percentile 205 n n n 68 n n n 471
Max 205 n n n 68 n n n 736
Scan length [cm] Median 15 n n n 14 n n n 15 15
number of exams 1 0 0 0 1 0 0 0 2
CTDI [mGy]
DLP [mGy.cm]
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Table B.5 Paediatric patients aged 5.5 to 10.5 years, facial bone CT without CM 
application. 
 
 
Table B.6 Paediatric patients aged 5.5 to 10.5 years, facial bone CT with CM 
application. 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 1 11 1 2 n 4 4 6 1
25th percentile 11 17 2 2 n 4 4 8 4
Median 15 23 2 2 n 4 5 8 8 11
75th percentile 17 28 2 2 n 5 15 8 14
Max 27 34 2 2 n 12 48 16 48
Min 13 134 22 32 n 48 36 75 13
25th percentile 118 273 25 32 n 56 51 109 58
Median 172 412 29 32 n 60 62 138 123 155
75th percentile 230 551 32 32 n 66 184 155 163
Max 274 690 35 32 n 96 983 300 983
Scan length [cm] Median 11 16 16 14 n 14 12 16 14 16
number of exams 12 2 2 1 0 8 15 17 57
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 13 n n n n 3 n 10 3
25th percentile 13 n n n n 4 n 10 5
Median 13 n n n n 4 n 10 10 12
75th percentile 13 n n n n 4 n 10 13
Max 13 n n n n 5 n 10 16
Min 170 n n n n 65 n 182 65
25th percentile 170 n n n n 70 n 182 86
Median 170 n n n n 76 n 182 170 176
75th percentile 170 n n n n 81 n 182 182
Max 170 n n n n 86 n 182 247
Scan length [cm] Median 13 n n n n 20 n 18 15 19
number of exams 1 1 0 0 0 2 0 1 5
CTDI [mGy]
DLP [mGy.cm]
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Table B.7 Paediatric patients aged 10.5 to 16 years, facial bone CT without CM 
application. 
 
 
Table B.8 Paediatric patients aged 10.5 to 16 years, facial bone CT with CM 
application. 
 
 
 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 1 6 2 2 n 4 4 6 1
25th percentile 1 11 2 2 n 5 7 8 5
Median 14 11 2 2 n 5 27 8 8 13
75th percentile 19 14 2 2 n 5 28 8 12
Max 28 15 2 2 n 12 38 16 38
Min 18 75 30 24 n 56 56 77 18
25th percentile 21 153 35 24 n 66 135 117 76
Median 155 195 40 24 n 74 268 128 129 175
75th percentile 225 216 40 24 n 81 452 138 209
Max 329 302 41 24 n 309 763 270 763
Scan length [cm] Median 13 17 17 12 n 15 16 16 15 17
number of exams 14 9 3 1 0 16 25 37 105
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 17 n 5 n n n n 40 5
25th percentile 17 n 5 n n n n 40 16
Median 17 n 5 n n n n 40 18 28
75th percentile 17 n 5 n n n n 40 19
Max 17 n 5 n n n n 40 40
Min 197 n 70 n n n n 617 79
25th percentile 197 n 70 n n n n 617 262
Median 197 n 70 n n n n 617 332 407
75th percentile 197 n 70 n n n n 617 404
Max 197 n 70 n n n n 617 810
Scan length [cm] Median 12 n 15 n n n n 16 18 15
number of exams 1 0 1 0 0 0 0 1 3
CTDI [mGy]
DLP [mGy.cm]
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C: The median value for CTDIvol, DLP and scan length of all eight centres for CT 
of the petrous bone with and without primary CM application separated by age 
group. 
 
Table C.1 Paediatric patients aged <1.5 years, petrous bone CT without CM 
application 
 
Paediatric patients aged <1.5 years, petrous bone CT with CM application: 
No such examinations were recorded at any of the participating centres. 
Table C.2 Paediatric patients aged 1.5 to 5.5 years, petrous bone CT without CM 
application. 
 
 
Center: A B C D E F H I All data DRL 75
Min 17 26 n n 13 17 n 11 11
25th percentile 17 28 n n 13 18 n 11 13
Median 17 29 n n 13 19 n 11 17 19
75th percentile 17 31 n n 13 20 n 11 26
Max 17 32 n n 13 21 n 13 35
Min 105 163 n n 70 76 n 62 62
25th percentile 105 170 n n 70 86 n 84 85
Median 105 177 n n 70 95 n 85 114 105
75th percentile 114 184 n n 70 105 n 102 179
Max 122 191 n n 70 114 n 179 240
Scan length [cm] Median 6 6 n n 5 5 n 8 6 6
number of exams 3 2 0 0 1 2 0 5 13
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 17 27 1 44 17 14 n 3 1
25th percentile 17 35 1 44 17 18 n 11 11
Median 17 36 1 44 17 21 n 11 18 29
75th percentile 19 40 1 44 17 23 n 11 35
Max 21 54 1 44 17 24 n 16 54
Min 118 162 12 186 88 98 n 43 12
25th percentile 133 218 12 269 88 104 n 67 88
Median 147 260 12 352 88 110 n 79 114 204
75th percentile 165 265 12 393 88 142 n 89 222
Max 182 378 12 435 88 228 n 106 435
Scan length [cm] Median 7 7 9 8 5 7 n 7 7 7
number of exams 3 6 1 3 1 7 0 11 32
CTDI [mGy]
DLP [mGy.cm]
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Paediatric patients aged 1.5 to 5.5 years, petrous bone CT with CM application: 
No such examinations were recorded at any of the participating centres. 
 
Table C.3 Paediatric patients aged 5.5 to 10.5 years, petrous bone CT without CM 
application. 
 
 
Table C.4 Paediatric patients aged 5.5 to 10.5 years, petrous bone with CM 
application. 
 
 
 
 
Center: A B C D E F H I All data DRL 75
Min 17 43 1 44 16 16 n 15 1
25th percentile 21 43 1 44 17 18 n 15 15
Median 21 43 1 44 17 22 n 15 18 32
75th percentile 21 43 1 44 17 23 n 15 40
Max 21 43 1 44 18 26 n 16 54
Min 131 291 10 261 74 106 n 93 10
25th percentile 163 291 10 274 101 121 n 106 107
Median 171 291 10 293 102 125 n 115 131 231
75th percentile 188 291 11 300 106 141 n 124 264
Max 201 291 11 386 112 170 n 209 397
Scan length [cm] Median 8 7 7 7 6 7 n 8 7 7
number of exams 6 1 2 6 6 7 0 16 44
CTDI [mGy]
DLP [mGy.cm]
Center: A B C D E F H I All data DRL 75
Min 21 n n n n n n n 21
25th percentile 21 n n n n n n n 21
Median 21 n n n n n n n 21 21
75th percentile 21 n n n n n n n 21
Max 21 n n n n n n n 21
Min 212 n n n n n n n 212
25th percentile 212 n n n n n n n 212
Median 212 n n n n n n n 212 212
75th percentile 212 n n n n n n n 212
Max 212 n n n n n n n 212
Scan length [cm] Median 10 n n n n n n n 10 10
number of exams 1 0 0 0 0 0 0 0 1
CTDI [mGy]
DLP [mGy.cm]
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Table C.5 Paediatric patients aged 10.5 to 16 years, petrous bone CT without CM 
application. 
 
 
Paediatric patients aged 10.5 to 16 years, petrous bone with CM application: 
No such examinations were recorded at any of the participating centres. 
 
Center: A B C D E F H I All data DRL 75
Min 21 35 n n 20 16 n 8 8
25th percentile 21 51 n n 20 18 n 15 15
Median 21 54 n n 20 27 n 15 21 27
75th percentile 21 54 n n 20 27 n 15 28
Max 21 54 n n 20 28 n 16 54
Min 131 162 n n 123 116 n 70 70
25th percentile 185 325 n n 123 134 n 102 131
Median 201 365 n n 123 147 n 117 180 201
75th percentile 212 430 n n 123 172 n 132 228
Max 238 450 n n 123 196 n 184 450
Scan length [cm] Median 9 8 n n 6 7 n 8 8 8
number of exams 11 8 0 0 1 5 0 11 36
CTDI [mGy]
DLP [mGy.cm]
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